Literature DB >> 6489422

Pharmacokinetics of S-adenosyl-L-methionine in healthy volunteers.

P Giulidori, M Cortellaro, G Moreo, G Stramentinoli.   

Abstract

S-Adenosyl-L-methionine (AdoMet) kinetics was studied in 6 male subjects given 100 and 500 mg i.v. Drug concentrations in plasma and urine were assayed using a radioenzymatic method. Pharmacokinetic parameters were estimated according to an open two-compartment model. The apparent volumes of distribution after the 100 and 500 mg doses were 407 +/- 27 and 443 +/- 36 ml/kg (mean +/- SEM), terminal half-lives 81 +/- 8 and 101 +/- 7 min and body clearances 3.7 +/- 0.5 and 3.1 +/- 0.2 ml/min per kg. Urinary excretion was 34 +/- 3 and 40 +/- 2% of the administered dose. The results demonstrate that drug disposition occurs more via metabolism than via renal excretion, and it is not dependent on the administered dose. Binding of AdoMet to serum proteins is negligible.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489422

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Pharmacokinetic studies of S-adenosyl-L-methionine (SAMe) in several animal species.

Authors:  G Stramentinoli; E Catto
Journal:  Pharmacol Res Commun       Date:  1976-04

2.  Comparison between the antidepressant activity and of S-adenosylmethionine (SAMe) and that of some tricyclic drugs.

Authors:  L Miccoli; V Porro; A Bertolino
Journal:  Acta Neurol (Napoli)       Date:  1978 May-Jun

3.  Influence of S-adenosyl-L-methionine on irreversible binding of ethynylestradiol to rat liver microsomes, and its implication in bile secretion.

Authors:  G Stramentinoli; M Gualano; P Rovagnati; C Di Padova
Journal:  Biochem Pharmacol       Date:  1979-04-01       Impact factor: 5.858

4.  Decrease of noradrenaline O-methylation in rat brain induced by L-dopa. Reversal effect of S-adenosyl-L-methionine.

Authors:  G Stramentinoli; E Catto; S Algeri
Journal:  J Pharm Pharmacol       Date:  1980-06       Impact factor: 3.765

5.  Protective role of S-adenosyl-l-methionine against acetaminophen induced mortality and hepatotoxicity in mice.

Authors:  G Stramentinoli; C Pezzoli; M Galli-Kienle
Journal:  Biochem Pharmacol       Date:  1979-12-15       Impact factor: 5.858

6.  NL-FIT: a microcomputer program for non-linear fitting.

Authors:  G S Landriani; V Guardabasso; M Rocchetti
Journal:  Comput Programs Biomed       Date:  1983 Feb-Apr

7.  Ethynylestradiol-induced impairment of bile secretion in the rat: protective effects of S-adenosyl-L-methionine and its implication in estrogen metabolism.

Authors:  G Stramentinoli; C Di Padova; M Gualano; P Rovagnati; M Galli-Kienle
Journal:  Gastroenterology       Date:  1981-01       Impact factor: 22.682

8.  Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration.

Authors:  M Frezza; G Pozzato; L Chiesa; G Stramentinoli; C di Padova
Journal:  Hepatology       Date:  1984 Mar-Apr       Impact factor: 17.425

9.  Open trial of S-adenosylmethionine for treatment of depression.

Authors:  J F Lipinski; B M Cohen; F Frankenburg; M Tohen; C Waternaux; R Altesman; B Jones; P Harris
Journal:  Am J Psychiatry       Date:  1984-03       Impact factor: 18.112

10.  Transmethylation, transsulfuration, and aminopropylation reactions of S-adenosyl-L-methionine in vivo.

Authors:  P Giulidori; M Galli-Kienle; E Catto; G Stramentinoli
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

View more
  3 in total

Review 1.  Metabolism of exogenous S-adenosyl-L-methionine in patients with liver disease.

Authors:  G L Kaye; J C Blake; A K Burroughs
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 2.  S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism.

Authors:  H A Friedel; K L Goa; P Benfield
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

3.  Pharmacokinetic study of a novel oral formulation of S-adenosylmethionine (MSI-195) in healthy subjects: dose escalation, food effect and comparison to a commercial nutritional supplement product.

Authors:  Beth R Cameron; Ludvina Ferreira; I David MacDonald
Journal:  BMC Pharmacol Toxicol       Date:  2020-12-14       Impact factor: 2.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.